Therapeutic effect of antithrombotic drug combinations in patients with atrial fibrillation undergoing percutaneous coronary intervention for coronary heart disease: a meta-analysis
CONCLUSIONS: DAT with NOACs has a higher safety profile against bleeding in patients with atrial fibrillation after PCI. DAT with VKAs was similar to TAT in terms of antithrombotic effect and incidence of bleeding.PMID:36628223 | PMC:PMC9827321
Source: American Journal of Translational Research - Category: Research Authors: Huabin He Xifeng Xiao Xiangyang Yuan Jianhai Chen Source Type: research
More News: Angioplasty | Atrial Fibrillation | Bleeding | Cardiology | Coronary Angioplasty | Coronary Heart Disease | Databases & Libraries | Heart | Heart Attack | Heart Disease | Percutaneous Coronary Intervention | Research | Stroke | Study | Thrombosis | Vitamin K | Vitamins